Related Experiment Videos
[Peripheral nerve stimulation in Alzheimer's disease]
1Vakgroep Klinische psychologie, Faculteit der psychologie en pedagogiek, Vrije Universiteit, Amsterdam.
Tijdschrift Voor Gerontologie En Geriatrie
|April 1, 1997
Summary
Transcutaneous Electrical Nerve Stimulation (TENS) improved memory and daily functioning in Alzheimer's disease (AD) patients. This peripheral nerve stimulation may offer a new strategy to enhance quality of life for individuals with AD.
Area of Science:
- Neuroscience
- Gerontology
- Neurology
Background:
- The
- use it or lose it
- concept suggests neuronal stimulation may counteract degeneration in aging and Alzheimer's disease (AD).
Purpose of the Study:
- To investigate the effects of Transcutaneous Electrical Nerve Stimulation (TENS), tactile stimulation, and their combination on memory and behavior in AD patients.
- To determine if TENS alone, without therapist presence, benefits cognitive and behavioral function and the rest-activity rhythm in AD patients.
Main Methods:
- Experimental groups received TENS and/or tactile stimulation; control groups received sham stimulation or interpersonal communication.
- Cognitive functions (memory, verbal fluency) and affective behavior were assessed.
- Rest-activity rhythm was monitored in a subsequent study.
Main Results:
- TENS and tactile stimulation significantly improved visual short-term memory, verbal and visual long-term memory, and verbal fluency compared to controls.
- Stimulated patients showed increased independence in daily activities and improved affective behavior.
- TENS alone, independent of therapist presence, improved cognitive functions and the rest-activity rhythm.
Conclusions:
- Peripheral nerve stimulation, particularly TENS, offers a promising therapeutic strategy for improving cognitive and behavioral outcomes in Alzheimer's disease.
- TENS may enhance the quality of life for AD patients by positively impacting memory, daily functioning, and sleep-wake cycles.
- The findings support the
- use it or lose it
- principle in the context of neurodegenerative disease management.